Modified Manufacturing Process for Abicipar Shows Modest Improvement in IOI Incidence
David Callahan, MDCredit: Texas Retina AssociatesA modified manufacturing process for 2mg abicipar pegol in the phase 2 MAPLE study was associated with a moderately lower...
